ALX-1393 is a selective inhibitor of GlyT2.

ALX1393 inhibits mechanical and cold hyperalgesia in a dose-dependent manner[2]. ALX1393 (i.c.v.; 25, 50, and 100 μg) in normal rats suppresses the late-phase response in the formalin test but does not affect motor performance.

949164-09-4

C23H22FNO4

395.42

ALX-1393

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years